This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Political / Trump's Acetaminophen-Autism Link,...
Domestic policy change

Trump's Acetaminophen-Autism Link, Leucovorin Approval

Analysis based on 10 articles · First reported Sep 22, 2025 · Last updated Sep 23, 2025

Sentiment
-20
Attention
6
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the new United States — Food and Drug Administration guidance on Paracetamol, potentially leading to decreased sales for Kenvue and other manufacturers. Conversely, the approval of Folinic acid for autism treatment and its Medicaid coverage could boost demand and sales for GSK plc and other companies producing similar drugs.

Pharmaceuticals Healthcare
Event Summary

President Donald Trump announced new United States — Food and Drug Administration guidance advising against acetaminophen use during pregnancy, citing a potential link to Autism, despite scientific disagreement. The administration, led by Donald Trump and Robert F. Kennedy Jr., also approved leucovorin for autism treatment, with Mehmet Oz confirming Medicaid coverage. Kenvue, the maker of Tylenol, strongly defended acetaminophen's safety, while the American College of Obstetricians and Gynecologists criticized the lack of scientific backing for the new guidance. Jay Bhattacharya also announced a $50 million investment in autism research. This event has sparked debate among medical experts and public health officials regarding the scientific basis of these policy changes and their potential impact on public health and pharmaceutical markets.

Entities Involved
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration was directed by Donald Trump to issue new guidance on acetaminophen and approved leucovorin for autism treatment, facing scrutiny for its scientific basis.
Importance 90.0 Sentiment -20.0
oth
Paracetamol
Paracetamol, the active ingredient in Tylenol, is at the center of the controversy, with new FDA guidance advising against its use during pregnancy due to a potential link to autism, despite scientific disagreement.
Importance 80.0 Sentiment -40.0
stock
Kenvue
Kenvue, the manufacturer of Tylenol, strongly disagreed with the suggestion that acetaminophen causes autism, defending the drug's safety and warning of risks from untreated fever or pain.
Importance 70.0 Sentiment -50.0
per
Robert F. Kennedy Jr.
Robert F. Kennedy Jr., as Health and Human Services Secretary, led the administration's autism initiative and promoted discredited theories linking vaccines to autism.
Importance 70.0 Sentiment -30.0
oth
Folinic acid
Folinic acid, a chemotherapy drug, received FDA approval for treating autism-related symptoms, with Medicaid expected to cover its cost, potentially increasing its market demand.
Importance 60.0 Sentiment 30.0
per
Marty Makary
Marty Makary, the United States — Food and Drug Administration Commissioner, announced the agency's actions regarding acetaminophen and leucovorin under the Trump administration's directive.
Importance 50.0 Sentiment -20.0
per
Mehmet Oz
Mehmet Oz, Centers for Medicare & Medicaid Services Administrator, confirmed Medicaid coverage for leucovorin in autism treatment, expressing confidence in private insurer follow-through.
Importance 40.0 Sentiment 10.0
per
Jay Bhattacharya
Jay Bhattacharya, National Institutes of Health Director, announced a $50 million investment in autism research projects.
Importance 40.0 Sentiment 10.0
ngo
American College of Obstetricians and Gynecologists
The American College of Obstetricians and Gynecologists contradicted the new FDA guidance, maintaining that acetaminophen is generally safe during pregnancy and criticizing the lack of scientific backing for the administration's announcement.
Importance 30.0 Sentiment 20.0
stock
GSK plc
GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.
Importance 20.0 Sentiment 10.0
cnt
United States
Importance 0.0 Sentiment 0.0
per
Donald Trump
Importance 0.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ Kenvue
United States — Food and Drug Administration related ↔ Robert F. Kennedy Jr.
United States — Food and Drug Administration related ↔ Marty Makary
United States — Food and Drug Administration related ↔ American College of Obstetricians and Gynecologists
United States — Food and Drug Administration related ↔ GSK plc
Kenvue related ↔ Robert F. Kennedy Jr.
Kenvue reliant company ↔ American College of Obstetricians and Gynecologists Kenvue relies on the clinical guidelines of the American College of Obstetricians and Gynecologists to defend its Tyleno
Robert F. Kennedy Jr. related ↔ Marty Makary
Robert F. Kennedy Jr. related ↔ Jay Bhattacharya
Robert F. Kennedy Jr. related ↔ American College of Obstetricians and Gynecologists
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.